As mentioned above, tumour cells may up-regulate PDL1 on their surface 34, 35, which engages the PD-1 receptor on activated T lymphocytes, thereby activating a signalling cascade that inhibits PI3K/Akt/mTOR axis 36, essential to induce glycolysis in effector T cells. The gene discussed is CD274; the disease is neoplasm.